Startseite KCNJ11 gene mutation analysis on nine Chinese patients with type 1B diabetes diagnosed before 3 years of age
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

KCNJ11 gene mutation analysis on nine Chinese patients with type 1B diabetes diagnosed before 3 years of age

  • Yanmei Sang EMAIL logo , Wenli Yang , Jie Yan und Yujun Wu
Veröffentlicht/Copyright: 3. April 2014

Abstract

Aim: The term type 1B diabetes mellitus (T1BDM) refers tonon-autoimmune-mediated type 1 diabetes. Recent studies revealed that monogenic mutations contribute to the genetic onset mechanism of this group. In this study, nine patients with T1BDM were selected as research subjects, and the 5′ untranslated region and the exon of KCNJ11 gene were sequenced in order to study the genetic onset mechanism of T1BDM.

Methods: Nine patients with T1BDM diagnosed before 3 years of age were selected as research subjects. Genomic DNA was extracted from peripheral leukocytes using standard procedures. The 5′ untranslated region and the exon of the KCNJ11 gene were sequenced using PCR-DNA assay techniques.

Results: A heterozygous c.1096G>T (G366W) mutation was identified in a patient diagnosed as type 1B diabetes at the age of 19 months, and the patient’s father carried the same mutation. The genotype of the patient’s mother was normal, indicating that this mutation was autosomal dominantly inherited. No KCNJ11 mutations were found in other patients. This patient suffered only from type 1B diabetes, not accompanied with neurological developmental abnormalities.

Conclusion: Monogenic mutation may be one of the main causes of early onset T1BDM. A KCNJ11 gene G366W mutation can lead to the onset of T1BDM in Chinese children. The patient with KCNJ11 G366W mutation suffered only type 1B diabetes, without neurological developmental abnormalities.


Corresponding author: Yanmei Sang, National Key Discipline of Pediatrics (Capital Medical University), Ministry of Education, Department of Endocrinology, Genetics and Metabolism, Beijing Children’s Hospital, Capital Medical University, Fuxingmenwai Nanlishi Road 56, Beijing 100045, China, Phone: 13910668087, Fax: 59718700, E-mail:

Acknowledgments

This work was supported by National Natural Science Foundation of China (Project No 81041016) and Program for Beijing Municipal Health Bureau Higher Excellent Talents, China (Project No 2011-3-051).

References

1. Bonfanti R, Colombo C, Nocerino V, Massa O, Lampasona V, et al. Insulin gene mutations as cause of diabetes in children negative for five type 1 diabetes autoantibodies. Diabetes Care 2009;32:123–5.10.2337/dc08-0783Suche in Google Scholar PubMed PubMed Central

2. Slingerland AS. Monogenic diabetes in children and young adults: Challenges for researcher, clinician and patient. Rev Endocr Metab Disord 2006;7:171–85.10.1007/s11154-006-9014-0Suche in Google Scholar PubMed PubMed Central

3. Hamilton-Shield JP. Overview of neonatal diabetes. Endocr Dev 2007;12:12–23.10.1159/000109601Suche in Google Scholar PubMed

4. Flanagan SE, Edghill EL, Gloyn AL, Ellard S, Hattersley AT. Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype. Diabetologia 2006;49:1190–7.10.1007/s00125-006-0246-zSuche in Google Scholar PubMed

5. Babenko AP, Polak M, Cave H, Busiah K, Czernichow P, et al. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. N Engl J Med 2006;355:456–66.10.1056/NEJMoa055068Suche in Google Scholar PubMed

6. Moritani M, Yokota I, Tsubouchi K, Takaya R, Takemoto K, et al. Identification of INS and KCNJ11 gene mutations in type 1B diabetes in Japanese children with onset of diabetes before 5 yr of age. Pediatr Diabetes 2013;14:112–20.10.1111/j.1399-5448.2012.00917.xSuche in Google Scholar PubMed

7. Edghill EL, Gloyn AL, Gillespie KM, Lambert AP, Raymond NT, et al. Activating mutations in the KCNJ11 gene encoding the ATP-sensitive K+ channel subunit Kir6.2 are rare in clinically defined type 1 diabetes diagnosed before 2 years. Diabetes 2004;53:2998–3001.10.2337/diabetes.53.11.2998Suche in Google Scholar PubMed

8. Yorifuji T, Nagashima K, Kurokawa K, Kawai M, Oishi M, et al. The C42R mutation in the Kir6.2 (KCNJ11) gene as a cause of transient neonatal diabetes, childhood diabetes, or later-onset, apparently type 2 diabetes mellitus. J Clin Endocrinol Metab 2005;90:3174–8.10.1210/jc.2005-0096Suche in Google Scholar PubMed

9. Hartemann-Heurtier A, Simon A, Bellanné-Chantelot C, Reynaud R, Cavé H, et al. Mutations in the ABCC8 gene can cause autoantibody-negative insulin-dependent diabetes. Diabetes Metab 2009;35:233–5.10.1016/j.diabet.2009.01.003Suche in Google Scholar PubMed

10. Gloyn AL, Diatloff-Zito C, Edgily EL, Bellanné-Chantelot C, Nivot S, et al. KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features. Eur J Hum Genet 2006;14: 824–30.10.1038/sj.ejhg.5201629Suche in Google Scholar PubMed

11. Sagen JV, Raeder H, Hathout E, Shehadeh N, Gudmundsson K, et al. Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy. Diabetes 2004;53:2713–8.10.2337/diabetes.53.10.2713Suche in Google Scholar PubMed

12. Flanagan SE, Patch AM, Mackay DJ, Edghill EL, Gloyn AL, et al. Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood. Diabetes 2007;56:1930–7.10.2337/db07-0043Suche in Google Scholar PubMed PubMed Central

13. 1Iafusco D, Stazi MA, Cotichini R, Cotellessa M, Martinucci ME, et al. Permanent diabetes mellitus in the first year of life. Diabetologia 2002;45:798–804.10.1007/s00125-002-0837-2Suche in Google Scholar PubMed

14. Landau Z, Wainstein J, Hanukoglu A, Tuval M, Lavie J, et al. Sulfonylurea-responsive diabetes in childhood. J Pediatr 2007;150:553–5.10.1016/j.jpeds.2007.03.004Suche in Google Scholar PubMed

15. Pearson ER, Flechtner I, Njolstad PR, Malecki MT, Flanagan SE, et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 2006;355:467–77.10.1056/NEJMoa061759Suche in Google Scholar PubMed

Received: 2013-4-25
Accepted: 2013-9-11
Published Online: 2014-4-3
Published in Print: 2014-5-1

©2014 by Walter de Gruyter Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Original articles
  3. Assessment of hearing in children with type 1 diabetes mellitus
  4. Insulin resistance and lipid profiles in HIV-infected Thai children receiving lopinavir/ritonavir-based highly active antiretroviral therapy
  5. Increased hunger and speed of eating in obese children and adolescents
  6. Glucagon and insulin cord blood levels in very preterm, late preterm and full-term infants
  7. Thyroid function in late preterm infants in relation to mode of delivery and respiratory support
  8. Prevalence of vitamin D deficiency and its related factors in children and adolescents living in North Khorasan, Iran
  9. Asymmetric dimethyl L-arginine, nitric oxide and cardiovascular disease in adolescent type 1 diabetics
  10. A combined nutritional-behavioral-physical activity intervention for the treatment of childhood obesity – a 7-year summary
  11. The effect of earlier puberty on cardiometabolic risk factors in Afro-Caribbean children
  12. Prevalence of risk of deficiency and inadequacy of 25-hydroxyvitamin D in US children: NHANES 2003–2006
  13. Serum uric acid: relationships with biomarkers in adolescents and changes over 1 year
  14. Psychological impact on parents of children with congenital adrenal hyperplasia: a study from Sri Lanka
  15. Investigation of adropin and leptin levels in pediatric obesity-related nonalcoholic fatty liver disease
  16. Diseases accompanying congenital hypothyroidism
  17. Molecular diagnosis of a Chinese pedigree with α-mannosidosis and identification of a novel missense mutation
  18. Are the characteristics of thyroid cancer different in young patients?
  19. Unsaturated fatty acids and insulin resistance in childhood obesity
  20. Effect of genetic subtypes and growth hormone treatment on bone mineral density in Prader-Willi syndrome
  21. KCNJ11 gene mutation analysis on nine Chinese patients with type 1B diabetes diagnosed before 3 years of age
  22. Prevalence and risk factors of metabolic syndrome in school adolescents of northeast China
  23. Patient reports
  24. A novel activating ABCC8 mutation underlying neonatal diabetes mellitus in an infant presenting with cerebral sinovenous thrombosis
  25. Endocrinological anomalies in a patient with 12q14 microdeletion syndrome. Completing phenotype of this exceptional short stature condition
  26. Acute mental status change as the presenting feature of adrenal insufficiency in a patient with autoimmune polyglandular syndrome type II and stroke
  27. Effect of ethosuximide on cortisol metabolism in the treatment of congenital adrenal hyperplasia
  28. Absence of WNT4 gene mutation in a patient with MURCS association
  29. Identification of a novel insulin receptor gene heterozygous mutation in a patient with type A insulin resistance syndrome
  30. Adrenal insufficiency in association with congenital nephrotic syndrome: a case report
  31. Diabetic lipemia presenting as eruptive xanthomas in a child with autoimmune polyglandular syndrome type IIIa
  32. A case report of nephrogenic diabetes insipidus with idiopathic Fanconi syndrome in a child who presented with vitamin D resistant rickets
  33. Letter to the Editor
  34. Hyperbilirubinemia in neonates of diabetic mothers: an indirect biomarker of organ damage?
Heruntergeladen am 23.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2013-0163/html
Button zum nach oben scrollen